What does a FibroScan result showing a liver stiffness of 10.9 kPa and a CAP value of 299 dB/m indicate?

FibroScan Interpretation: CAP 299 dB/m and LSM 10.9 kPa

Your FibroScan shows moderate hepatic steatosis (liver fat) and suggests borderline advanced fibrosis (F3), placing you at significant risk for progressive liver disease that requires clinical action and lifestyle intervention.

Liver Stiffness (10.9 kPa) - Fibrosis Assessment

Your liver stiffness of 10.9 kPa falls into a critical diagnostic zone:

• For NAFLD/metabolic liver disease: This value sits at the threshold for advanced fibrosis (F3-F4). The 2025 AASLD guidelines indicate that 10 kPa cutoff has 82% sensitivity and 79% specificity for detecting advanced fibrosis 1. Your value of 10.9 kPa suggests you likely have F3 (advanced fibrosis) or are at high risk for it.

• Important caveat: Research demonstrates that moderate-to-severe steatosis can artificially elevate liver stiffness measurements in patients without true advanced fibrosis 2, 3. In one study, 35% of patients with early fibrosis (F0-F1) but moderate-to-severe steatosis were misdiagnosed as having significant fibrosis 4. Your CAP of 299 dB/m places you in the middle tertile where this overestimation effect occurs 3.

Clinical Algorithm for Your LSM Value:

1. Repeat FibroScan in 6-12 months - One-third of patients with LSM >12 kPa show reversal after 4-6 months, and these patients typically don't have advanced fibrosis on biopsy 5

2. Consider liver biopsy if clinical decision-making requires definitive staging, especially if:

   • Treatment decisions depend on fibrosis stage
   • You have other risk factors (diabetes, ongoing alcohol use, viral hepatitis)
   • LSM remains elevated on repeat testing

3. Combine with FIB-4 score: Using FIB-4 with LSM cutoffs (<8.8 kPa excludes advanced fibrosis; >10.9 kPa suggests advanced fibrosis) provides 89% sensitivity and 82% specificity 2

CAP Score (299 dB/m) - Steatosis Assessment

Your CAP of 299 dB/m indicates moderate hepatic steatosis (S2):

• Steatosis grading 6:

  • S≥1 (any steatosis): >302 dB/m
  • S≥2 (moderate): >331 dB/m
  • S3 (severe): >337 dB/m

• Your value of 299 dB/m falls just below the S≥1 threshold, suggesting mild-to-moderate steatosis (likely S1-S2 range)

• BMI consideration: CAP values are significantly affected by body mass index. If you're obese (BMI ≥30), the cutoffs shift higher (285 dB/m for S≥1,340 dB/m for S≥2) 7. Without knowing your BMI, interpretation has some uncertainty.

Critical Action Points

You need immediate clinical intervention because:

1. Liver stiffness of 10.9 kPa indicates you're at or approaching advanced fibrosis, which significantly increases risk of cirrhosis, liver failure, and hepatocellular carcinoma

2. This is NOT a "watch and wait" scenario - Advanced fibrosis (F3) represents the last stage before cirrhosis where significant reversal is still possible with aggressive intervention

3. Weight loss and increased physical activity can reduce both LSM and CAP 5:

   • Patients losing ≥1 kg showed 3.6 kPa reduction in LSM
   • CAP decreased by 39 dB/m with weight loss
   • These lifestyle changes can reverse apparent "advanced fibrosis" if steatosis is contributing to elevated LSM

Recommended Next Steps

1. Lifestyle modification (urgent):

   • Target ≥7-10% body weight loss
   • Increase physical activity
   • Eliminate alcohol completely
   • Optimize metabolic factors (diabetes, lipids, blood pressure)

2. Repeat FibroScan in 6 months to assess:

   • Response to lifestyle changes
   • Whether LSM decreases (suggesting steatosis was inflating the value)
   • Whether LSM remains elevated (confirming true advanced fibrosis)

3. Calculate FIB-4 score using age, AST, ALT, and platelet count to corroborate findings 2

4. Screen for hepatocellular carcinoma if LSM remains >10 kPa on repeat testing, as this suggests true advanced fibrosis requiring surveillance

5. Consider hepatology referral for potential liver biopsy if diagnostic uncertainty persists or if clinical management depends on definitive staging

Common Pitfalls to Avoid

• Don't assume 10.9 kPa definitively means F3 fibrosis - Your moderate steatosis may be inflating this value by 1-2 kPa 3
• Don't delay lifestyle intervention - Even if steatosis is contributing to the elevated LSM, you still have significant liver disease requiring immediate action
• Don't use a single FibroScan to make irreversible treatment decisions - Serial measurements provide much better diagnostic accuracy 5
• Don't ignore this result - Values >10 kPa warrant close follow-up regardless of the exact fibrosis stage